Analyzing Hims & Hers Health (HIMS) and Its Rivals

Hims & Hers Health (NYSE:HIMS) is one of 60 public companies in the “MEDICAL INFO SYS” industry, but how does it weigh in compared to its rivals? We will compare Hims & Hers Health to similar businesses based on the strength of its valuation, profitability, earnings, analyst recommendations, institutional ownership, dividends and risk.

Risk & Volatility

Hims & Hers Health has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500. Comparatively, Hims & Hers Health’s rivals have a beta of 1.80, indicating that their average stock price is 80% more volatile than the S&P 500.

Valuation & Earnings

This table compares Hims & Hers Health and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Hims & Hers Health	$1.48 billion	$126.04 million	72.79
Hims & Hers Health Competitors	$429.86 million	-$62.41 million	5.65

Hims & Hers Health has higher revenue and earnings than its rivals. Hims & Hers Health is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Insider & Institutional Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 42.3% of shares of all “MEDICAL INFO SYS” companies are held by institutional investors. 13.7% of Hims & Hers Health shares are held by insiders. Comparatively, 17.9% of shares of all “MEDICAL INFO SYS” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Hims & Hers Health and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	9.24%	22.75%	15.51%
Hims & Hers Health Competitors	-194.24%	-97.38%	-20.44%

Analyst Recommendations

This is a breakdown of recent recommendations for Hims & Hers Health and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	3	8	2	0	1.92
Hims & Hers Health Competitors	252	741	1826	23	2.57

Hims & Hers Health currently has a consensus price target of $39.58, suggesting a potential downside of 21.19%. As a group, “MEDICAL INFO SYS” companies have a potential upside of 26.85%. Given Hims & Hers Health’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Hims & Hers Health has less favorable growth aspects than its rivals.

Summary

Hims & Hers Health beats its rivals on 8 of the 13 factors compared.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.